da Costa Rodrigues T, Zorzete P, Miyaji E, Goncalves V
Appl Microbiol Biotechnol. 2024; 108(1):281.
PMID: 38570417
PMC: 10990985.
DOI: 10.1007/s00253-024-13098-2.
Li S, Liang H, Zhao S, Yang X, Guo Z
Front Immunol. 2023; 14:1278346.
PMID: 37818378
PMC: 10560988.
DOI: 10.3389/fimmu.2023.1278346.
Lane J, Tata M, Briles D, Orihuela C
Front Cell Infect Microbiol. 2022; 12:826264.
PMID: 35186799
PMC: 8847780.
DOI: 10.3389/fcimb.2022.826264.
Park S, Gonzalez-Juarbe N, Martinez E, Hale J, Lin Y, Huffines J
mBio. 2021; 12(3).
PMID: 33947761
PMC: 8437407.
DOI: 10.1128/mBio.00673-21.
Dzaraly N, Desa M, Muthanna A, Masri S, Mohd Taib N, Suhaili Z
Sci Rep. 2021; 11(1):8220.
PMID: 33859249
PMC: 8050075.
DOI: 10.1038/s41598-021-87428-z.
Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection.
Huang J, Gingerich A, Royer F, Paschall A, Pena-Briseno A, Avci F
Infect Immun. 2021; 89(5.
PMID: 33649050
PMC: 8091081.
DOI: 10.1128/IAI.00747-20.
PspA Diversity, Serotype Distribution and Antimicrobial Resistance of Invasive Pneumococcal Isolates from Paediatric Patients in Shenzhen, China.
Jiang H, Meng Q, Liu X, Chen H, Zhu C, Chen Y
Infect Drug Resist. 2021; 14:49-58.
PMID: 33469319
PMC: 7810716.
DOI: 10.2147/IDR.S286187.
Virulence-Associated Characteristics of Serotype 14 and Serogroup 9 Clones Circulating in Brazil: Association of Penicillin Non-susceptibility With Transparent Colony Phenotype Variants.
Pinto T, Costa N, Pina S, Souza A, Oliveira L, Moura C
Front Microbiol. 2020; 11:2009.
PMID: 32983022
PMC: 7479199.
DOI: 10.3389/fmicb.2020.02009.
The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA.
Genschmer K, Vadesilho C, McDaniel L, Park S, Hale Y, Miyaji E
mSphere. 2019; 4(6).
PMID: 31826968
PMC: 6908419.
DOI: 10.1128/mSphere.00589-19.
Prevalence of PspA families and pilus islets among Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil.
Knupp-Pereira P, Marques N, Teixeira L, Povoa H, Neves F
Braz J Microbiol. 2019; 51(2):419-425.
PMID: 31802411
PMC: 7203294.
DOI: 10.1007/s42770-019-00179-y.
Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.
Zhang Y, Guo X, Guo M, Chen X, Li B, Yu J
Immunol Res. 2019; 67(4-5):398-407.
PMID: 31773490
DOI: 10.1007/s12026-019-09107-6.
Protective responses of an engineered PspA recombinant antigen against .
Akbari E, Negahdari B, Faraji F, Behdani M, Kazemi-Lomedasht F, Habibi-Anbouhi M
Biotechnol Rep (Amst). 2019; 24:e00385.
PMID: 31763198
PMC: 6864353.
DOI: 10.1016/j.btre.2019.e00385.
Identification of evolutionarily conserved virulence factor by selective pressure analysis of .
Yamaguchi M, Goto K, Hirose Y, Yamaguchi Y, Sumitomo T, Nakata M
Commun Biol. 2019; 2:96.
PMID: 30886906
PMC: 6408437.
DOI: 10.1038/s42003-019-0340-7.
Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
Chen X, Li B, Yu J, Zhang Y, Mo Z, Gu T
Med Microbiol Immunol. 2019; 208(2):215-226.
PMID: 30707297
DOI: 10.1007/s00430-019-00579-9.
The diversity of the proline-rich domain of pneumococcal surface protein A (PspA): Potential relevance to a broad-spectrum vaccine.
Mukerji R, Hendrickson C, Genschmer K, Park S, Bouchet V, Goldstein R
Vaccine. 2018; 36(45):6834-6843.
PMID: 30293761
PMC: 6366627.
DOI: 10.1016/j.vaccine.2018.08.045.
Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments.
Lu J, Guo J, Wang D, Yu J, Gu T, Jiang C
Hum Vaccin Immunother. 2018; 15(2):371-380.
PMID: 30235046
PMC: 6422497.
DOI: 10.1080/21645515.2018.1526556.
Molecular Characterization of Pneumococcal Surface Protein A (PspA), Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Strains Isolated from Pakistan.
Khan F, Khan M, Ahmed N, Khan M, Bashir H, Tahir S
Infect Dis Ther. 2018; 7(2):277-289.
PMID: 29524198
PMC: 5986679.
DOI: 10.1007/s40121-018-0195-0.
Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
da Silva M, Converso T, Goncalves V, Leite L, Tanizaki M, Barazzone G
Clin Vaccine Immunol. 2017; 24(8).
PMID: 28637805
PMC: 5583475.
DOI: 10.1128/CVI.00118-17.
Towards Identifying Protective B-Cell Epitopes: The PspA Story.
Khan N, Jan A
Front Microbiol. 2017; 8:742.
PMID: 28512452
PMC: 5411445.
DOI: 10.3389/fmicb.2017.00742.
Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae.
Kristian S, Ota T, Bubeck S, Cho R, Groff B, Kubota T
PLoS One. 2016; 11(5):e0154616.
PMID: 27171010
PMC: 4865217.
DOI: 10.1371/journal.pone.0154616.